3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Breast Neoplasms
71
Neoplasms
70
Lung Neoplasms
29
Prostatic Neoplasms
26
Head and Neck Neoplasms
22
Colorectal Neoplasms
19
Uterine Cervical Neoplasms
17
Ovarian Neoplasms
13
Neoplasm Metastasis
13
Motor Activity
13
Fatigue
11
Endometrial Neoplasms
11
Colonic Neoplasms
11
Brain Neoplasms
11
Pain
10
Carcinoma, Non-Small-Cell Lung
10
Multiple Myeloma
9
Melanoma
9
Rectal Neoplasms
8
Leukemia
8
Gastrointestinal Neoplasms
8
Smoking Cessation
7
Pancreatic Neoplasms
7
Lymphoma
7
Depression
7
cyclopia sequence
6
Esophageal Neoplasms
6
Carcinoma, Renal Cell
6
Advanced Cancer
6
Uterine Neoplasms
5
Interventions
pembrolizumab
2
Imatinib Mesylate
2
Cisplatin
2
Axitinib
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
2
tislelizumab
1
regorafenib
1
gallium 68 PSMA-11
1
avelumab
1
Tretinoin
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Radiation
1
Quality of Life
1
Patient Reported Outcome Measures
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
GSK-3326595
1
Everolimus
1
Etoposide
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Bortezomib
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Adenoid Cystic
×
Surveys and Questionnaires
×
Clear all
NCT06535997
2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
62 enrolled